News & Updates

Second primary melanoma tied to better survival than single primary lesion
Second primary melanoma tied to better survival than single primary lesion
06 May 2023

Patients who present with second primary melanomas have better survival and thinner lesions than those presenting with single primary melanomas, reveals a study.

Second primary melanoma tied to better survival than single primary lesion
06 May 2023
Hysteroscopic resection outdoes ultrasound-guided D&E for caesarean scar ectopic pregnancy
Hysteroscopic resection outdoes ultrasound-guided D&E for caesarean scar ectopic pregnancy
06 May 2023

Treatment success of caesarean scar ectopic pregnancy appears to be higher with hysteroscopic resection than with ultrasound-guided dilation and evacuation (D&E), according to a study.

Hysteroscopic resection outdoes ultrasound-guided D&E for caesarean scar ectopic pregnancy
06 May 2023
COVID-19 long-term sequelae and complications
COVID-19 long-term sequelae and complications
06 May 2023 byElvira Manzano

Long COVID, sometimes referred to as post-acute sequelae of COVID-19, is still highly prevalent despite improved acute treatments, the emergence of newer variants, and wider vaccination coverage, says an expert at ECCMID 2023.

COVID-19 long-term sequelae and complications
06 May 2023
Perampanel for idiopathic generalized epilepsy passes muster in real world
Perampanel for idiopathic generalized epilepsy passes muster in real world
05 May 2023
Fluvoxamine plus budesonide helps prevent severe COVID-19
Fluvoxamine plus budesonide helps prevent severe COVID-19
05 May 2023

High-risk outpatients with early-onset COVID-19 who are treated with oral fluvoxamine plus inhaled budesonide have a reduced incidence of severe disease that warrants advanced care, reveals a study.

Fluvoxamine plus budesonide helps prevent severe COVID-19
05 May 2023
Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
05 May 2023 byAudrey Abella

Good quality surgery conferred a progression-free survival (PFS) benefit for women with ovarian sex cord stromal tumours (SCST) in the first-line setting and on first and second relapse. Chemotherapy, on the other hand, had no impact on survival in the first-line or relapse setting.

Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
05 May 2023